Influenza is an infectious viral disease that can result in serious complications, such as myocarditis and pneumonia in many patients. The acute course of the disease is a threat not only to the health, but even to the life of the patient. Because of the mutation of the influenza virus, immunizations are recommended each year before the fall and winter seasons. We provide flu virus vaccinations for adults and children.
Human papilloma viruses are most commonly transmitted sexually, during sexual contact. HPV - Human Papilloma Virus is a highly oncogenic virus. It is the most common cause of cervical cancer, the second most common malignancy in women. HPV vaccination can reduce the likelihood of HPV infection by up to 90% and significantly reduce the risk of precancerous and cancerous genital lesions.
Hepatitis B is caused by the Hepatitis B Virus (HBV). It is one of the most hazardous infectious diseases affecting people of all ages. Its acute or chronic course can lead to dangerous disease complications, cirrhosis, hepatocellular carcinoma, and even death of the patient. A full course of HBV vaccination provides effective and long-lasting protection against infection.
Pertussis (whooping cough) is a dangerous infectious disease that causes acute respiratory distress, attacks of chronic cough, breathing problems, and can even lead to death in infants. Pertussis vaccination is mandatory, and the vaccination cycle is carried out in the first months of a child's life. To protect an infant from the first days of life, it is recommended that pregnant women receive the pertussis vaccination in the second trimester of pregnancy. This allows the antibodies produced by the mother to enter the baby's body through the placenta and help the baby develop its own natural immunity.
In the case of Rh-negative pregnant women, prevention of serological conflict during the pregnancy is recommended by administering anti-D immnuoglobulin. It is most often performed in the 28th-34th week of gestation, and also after the end of pregnancy in selected cases. This prevention allows a reduction in the risk of serological conflict and hemolytic disease between mother and fetus, almost by 100%, and also allows preparation of the mother's body for the next pregnancy.